IL151211A0 - Compositions useful for regulating parkin gene activity - Google Patents
Compositions useful for regulating parkin gene activityInfo
- Publication number
- IL151211A0 IL151211A0 IL15121101A IL15121101A IL151211A0 IL 151211 A0 IL151211 A0 IL 151211A0 IL 15121101 A IL15121101 A IL 15121101A IL 15121101 A IL15121101 A IL 15121101A IL 151211 A0 IL151211 A0 IL 151211A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions useful
- gene activity
- parkin gene
- regulating
- regulating parkin
- Prior art date
Links
- 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 101710176122 28 kDa heat- and acid-stable phosphoprotein Proteins 0.000 abstract 1
- 102100027336 Regenerating islet-derived protein 3-alpha Human genes 0.000 abstract 1
- 102000045222 parkin Human genes 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0001980A FR2805266B1 (fr) | 2000-02-17 | 2000-02-17 | Compositions utilisables pour reguler l'activite de la parkine |
| US19848900P | 2000-04-18 | 2000-04-18 | |
| PCT/FR2001/000461 WO2001060857A2 (fr) | 2000-02-17 | 2001-02-15 | Compositions utilisables pour reguler l'activite de la parkine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL151211A0 true IL151211A0 (en) | 2003-04-10 |
Family
ID=26212182
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15121101A IL151211A0 (en) | 2000-02-17 | 2001-02-15 | Compositions useful for regulating parkin gene activity |
| IL151211A IL151211A (en) | 2000-02-17 | 2002-08-12 | A polypeptide that interacts with the parkin gene, pharmacological compositions containing it for use in the treatment of neurodegenerative pathologies and a method for its preparation |
| IL193310A IL193310A (en) | 2000-02-17 | 2008-08-07 | An antibody against a polypeptide which reacts with Parkin and medicinal preparations containing it |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL151211A IL151211A (en) | 2000-02-17 | 2002-08-12 | A polypeptide that interacts with the parkin gene, pharmacological compositions containing it for use in the treatment of neurodegenerative pathologies and a method for its preparation |
| IL193310A IL193310A (en) | 2000-02-17 | 2008-08-07 | An antibody against a polypeptide which reacts with Parkin and medicinal preparations containing it |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7132396B2 (no) |
| EP (1) | EP1259606B1 (no) |
| KR (1) | KR100811926B1 (no) |
| AT (1) | ATE466083T1 (no) |
| AU (1) | AU2001235696A1 (no) |
| BR (1) | BR0108376A (no) |
| CA (1) | CA2400256C (no) |
| CY (1) | CY1111004T1 (no) |
| DE (1) | DE60141948D1 (no) |
| IL (3) | IL151211A0 (no) |
| MX (1) | MXPA02007869A (no) |
| NO (1) | NO20023914L (no) |
| NZ (1) | NZ520802A (no) |
| WO (1) | WO2001060857A2 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002357850A1 (en) * | 2001-12-14 | 2003-06-30 | Incyte Genomics, Inc. | Neurotransmission-associated proteins |
| US8138307B2 (en) * | 2003-02-18 | 2012-03-20 | Cedars-Sinai Medical Center | Parkin interacting polypeptides and methods of use |
| US20090069189A1 (en) * | 2007-09-11 | 2009-03-12 | Cancer Prevention And Cure, Ltd. | Method of identifying proteins in human serum indicative of pathologies of human lung tissues |
| CN109297780B (zh) * | 2018-10-23 | 2021-01-01 | 东华理工大学 | 一种液塑限联合测定法中的取样方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2449501A (en) * | 1999-12-21 | 2001-07-03 | Incyte Genomics, Inc. | Vesicle trafficking proteins |
| WO2001053312A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| US20030220240A1 (en) * | 2000-12-21 | 2003-11-27 | Tang Y. Tom | Vesicle trafficking proteins |
-
2001
- 2001-02-15 WO PCT/FR2001/000461 patent/WO2001060857A2/fr active Application Filing
- 2001-02-15 AU AU2001235696A patent/AU2001235696A1/en not_active Abandoned
- 2001-02-15 NZ NZ520802A patent/NZ520802A/en not_active IP Right Cessation
- 2001-02-15 MX MXPA02007869A patent/MXPA02007869A/es active IP Right Grant
- 2001-02-15 EP EP01907820A patent/EP1259606B1/fr not_active Expired - Lifetime
- 2001-02-15 KR KR1020027010630A patent/KR100811926B1/ko not_active IP Right Cessation
- 2001-02-15 AT AT01907820T patent/ATE466083T1/de active
- 2001-02-15 DE DE60141948T patent/DE60141948D1/de not_active Expired - Lifetime
- 2001-02-15 CA CA2400256A patent/CA2400256C/fr not_active Expired - Fee Related
- 2001-02-15 IL IL15121101A patent/IL151211A0/xx unknown
- 2001-02-15 BR BR0108376-7A patent/BR0108376A/pt active Search and Examination
- 2001-02-20 US US09/785,548 patent/US7132396B2/en not_active Expired - Fee Related
-
2002
- 2002-08-12 IL IL151211A patent/IL151211A/en not_active IP Right Cessation
- 2002-08-16 NO NO20023914A patent/NO20023914L/no not_active Application Discontinuation
-
2006
- 2006-03-28 US US11/390,195 patent/US8273548B2/en not_active Expired - Fee Related
-
2008
- 2008-08-07 IL IL193310A patent/IL193310A/en not_active IP Right Cessation
-
2010
- 2010-07-27 CY CY20101100700T patent/CY1111004T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20020155577A1 (en) | 2002-10-24 |
| CY1111004T1 (el) | 2015-06-11 |
| US7132396B2 (en) | 2006-11-07 |
| IL151211A (en) | 2010-05-31 |
| NO20023914L (no) | 2002-10-11 |
| KR20020089352A (ko) | 2002-11-29 |
| EP1259606A2 (fr) | 2002-11-27 |
| US8273548B2 (en) | 2012-09-25 |
| NO20023914D0 (no) | 2002-08-16 |
| IL193310A (en) | 2011-12-29 |
| ATE466083T1 (de) | 2010-05-15 |
| CA2400256A1 (fr) | 2001-08-23 |
| DE60141948D1 (de) | 2010-06-10 |
| CA2400256C (fr) | 2014-09-09 |
| BR0108376A (pt) | 2003-03-11 |
| US20060287230A1 (en) | 2006-12-21 |
| MXPA02007869A (es) | 2003-02-10 |
| IL193310A0 (en) | 2011-08-01 |
| AU2001235696A1 (en) | 2001-08-27 |
| WO2001060857A3 (fr) | 2002-06-20 |
| NZ520802A (en) | 2005-02-25 |
| EP1259606B1 (fr) | 2010-04-28 |
| KR100811926B1 (ko) | 2008-03-10 |
| WO2001060857A2 (fr) | 2001-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3368497A (en) | Human dnase i hyperactive variants | |
| MY134136A (en) | Novel compounds comprising jak3 kinase inhibitors | |
| IL148243A0 (en) | Trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and pharmaceutical compositions containing the same | |
| IL151313A0 (en) | Lipase containing pharmaceutical compositions | |
| AU2845599A (en) | Pharmaceutical compositions and their use | |
| WO2002044320A3 (en) | Human elongase genes and uses thereof | |
| AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
| AUPP589598A0 (en) | Novel peptides | |
| WO2004054607A3 (de) | Stabile therapeutische proteine | |
| AU4363199A (en) | Use of hmg proteins for the preparation of medicaments having cytotoxic activity | |
| AU2002212505A1 (en) | Dna expression vectors | |
| WO2001012661A3 (en) | RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-xL FUSION PROTEIN INHIBITS APOPTOSIS | |
| WO2000037487A8 (de) | INHIBITOREN DES INTEGRINS αvβ¿6? | |
| CY1111004T1 (el) | Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης | |
| MXPA05010575A (es) | Peptacuerpo para el tratamiento del cancer. | |
| AU7216498A (en) | Inhibitors of the urokinase receptor | |
| WO2001064876A3 (en) | Human schizophrenia gene | |
| WO2003076658A3 (en) | A susceptibility gene for late-onset idiopathic parkinson's disease | |
| AUPO089396A0 (en) | Neuroactive peptide | |
| GB0221169D0 (en) | Crystal | |
| AU2001249267A1 (en) | Methods and compositions for elucidating protein expression profiles in cells | |
| AU2003227622A1 (en) | Methylthiophene carboxanilides | |
| WO1999050671A3 (en) | Toso as a target for drug screening | |
| AU5155699A (en) | Peptides for inhibiting hpv e7 proteins | |
| WO2002012336A3 (en) | TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE |